GRAIL, Inc. Common Stock (GRAL) Stock Price

GRALStock

$80.00+134.54%52W

Market Cap$3.57B

P/E—

PEG Ratio—

Div yield—

Beta1.64

GRAL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)46.96%

Price vs S&P 500 (4W)12.30%

VGM Score61.76

Book Value / Share (Quarterly)$56.93

P/TBV (Annual)4.59x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)38.37%

Cash Flow / Share (Quarterly)$-6.63

Price vs S&P 500 (YTD)-19.35%

Gross Margin (TTM)49.71%

Net Profit Margin (TTM)-236.95%

EPS (TTM)$-9.75

10-Day Avg Trading Volume0.72M

EPS Excl Extra (TTM)$-9.75

EPS (Annual)$-11.11

ROI (Annual)-15.84%

Gross Margin (Annual)48.46%

Net Profit Margin (5Y Avg)-4344.87%

Cash / Share (Quarterly)$19.29

Revenue Growth QoQ (YoY)25.72%

ROA (Last FY)-13.97%

Revenue Growth TTM (YoY)23.07%

EBITD / Share (TTM)$-10.59

ROE (5Y Avg)-53.29%

Operating Margin (TTM)-338.40%

Cash Flow / Share (Annual)$-7.44

P/B Ratio1.20x

P/B Ratio (Quarterly)1.15x

Net Income / Employee (Annual)$-448,700

EV / Revenue (TTM)18.11x

ROA (TTM)-14.02%

EPS Incl Extra (Annual)$-11.11

Current Ratio (Annual)11.97x

Quick Ratio (Quarterly)10.55x

3-Month Avg Trading Volume0.68M

52-Week Price Return134.54%

Revenue / Employee (TTM)$181,600

Tangible BV / Share (Quarterly)$17.04

P/S Ratio (Annual)20.71x

Asset Turnover (Annual)0.05x

52-Week High$118.84

Operating Margin (5Y Avg)-4442.08%

EPS Excl Extra (Annual)$-11.11

CapEx CAGR (5Y)-22.88%

26-Week Price Return58.89%

Quick Ratio (Annual)11.58x

13-Week Price Return8.23%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)10.95x

Enterprise Value$2.99B

Asset Turnover (TTM)0.06x

Revenue / Employee (Annual)$161,700

Pretax Margin (Annual)-363.18%

Cash / Share (Annual)$22.43

3-Month Return Std Dev77.11%

Gross Margin (5Y Avg)37.30%

Net Income / Employee (TTM)$-430,300

ROE (Last FY)-15.84%

EPS Basic Excl Extra (Annual)$-11.11

Receivables Turnover (TTM)9.16x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-9.75

Receivables Turnover (Annual)7.62x

ROI (TTM)-15.88%

P/S Ratio (TTM)18.44x

Pretax Margin (5Y Avg)-4431.73%

Revenue / Share (Annual)$4.00

Tangible BV / Share (Annual)$18.03

Price vs S&P 500 (52W)115.98%

Year-to-Date Return-6.53%

5-Day Price Return4.47%

EPS Normalized (Annual)$-11.11

ROA (5Y Avg)-48.30%

Net Profit Margin (Annual)-277.47%

Month-to-Date Return16.69%

EBITD / Share (Annual)$-11.37

Operating Margin (Annual)-381.98%

ROI (5Y Avg)-53.29%

EPS Basic Excl Extra (TTM)$-9.75

P/TBV (Quarterly)3.85x

P/B Ratio (Annual)1.29x

Inventory Turnover (TTM)8.50x

Pretax Margin (TTM)-320.38%

Book Value / Share (Annual)$63.92

Price vs S&P 500 (13W)6.27%

Beta1.64x

Revenue / Share (TTM)$3.83

ROE (TTM)-15.88%

52-Week Low$30.82

vGradeD

gGradeA

mGradeB

vgmGradeB

GRAL Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$2.43	-$1.34	+44.92%(+$1.09)
Q1 2026	May 5, 2026	-$1.96	-$1.37	+30.06%(+$0.59)
Q4 2025	Feb 19, 2026	-$2.53	-$2.44	+3.63%(+$0.09)
Q3 2025	Nov 12, 2025	-$3.27	-$2.46	+24.66%(+$0.81)
Q2 2025	Aug 12, 2025	-$3.56	-$3.18	+10.76%(+$0.38)

GRAL Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.93

3.87

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
GRALGRAIL, Inc. Common Stock	D	A	B	$80.00
NTRANatera, Inc. Common Stock	F	A	B	$326.26
LHLabcorp Holdings Inc.	C	D	B	$335.11
DGXQuest Diagnostics Inc.	C	D	B	$242.76
GHGuardant Health, Inc. Common Stock	F	A	B	$161.50
CAICaris Life Sciences, Inc. Common Stock	F	A	C	$25.63
RDNTRadNet, Inc. Common Stock	D	C	B	$74.61
BLLNBillionToOne, Inc. Class A Common Stock	F	F	D	$93.24
CELCCelcuity Inc. Common Stock	—	—	C	$88.44
VCYTVeracyte, Inc.	D	A	C	$43.34
CDNACareDx, Inc.	D	B	A	$49.79
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.07
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.81
FRNMFreenome, Inc. Common stock	—	F	A	$14.79
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	C	$11.51
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$33.50
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.61
YDESYD Bio Limited Ordinary Shares	—	—	C	$4.80
BDSXBiodesix, Inc. Common Stock	D	B	A	$26.83
XGNExagen Inc. Common Stock	D	B	C	$7.39
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$10.19
SERASera Prognostics, Inc. Class A Common Stock	D	D	D	$2.07
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.72
ADVBAdvanced Biomed Inc. Common Stock	A	—	A	$9.70
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	F	$2.40
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	C	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.42

About GRAIL, Inc. Common Stock

GRAIL Inc develops a blood-based test for multi-cancer early detection designed to identify various cancer types at earlier stages. The company provides testing services focused on enabling earlier diagnosis and intervention, operating as a single business segment dedicated to cancer detection technology.